Skip to content

The Association of Omentin and Ischemic Stroke

The Association of Omentin and Ischemic Stroke

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03125759
Enrollment
2000
Registered
2017-04-24
Start date
2017-01-01
Completion date
2025-12-31
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adipokines, Brain Ischemia, Mutation, Stroke

Keywords

Ischemic Stroke, Omentin

Brief summary

This observational study aims to research whether there is a relationship between omentin and ischemic stroke on the aspects of incidence, severity, and recovery etc.

Detailed description

To study the possible relationship between omentin and ischemic stroke, we intend to recruit the newly found acute ischemic stroke patients and patients without any stroke history and analysis the difference of plasma omentin level and the ITLN, which is the gene symbol of omentin.

Interventions

None listed

Sponsors

Xi'an No.3 Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* For ischemic stroke group,acute clinically defined ischemic stroke * For control group, without any history of stroke

Exclusion criteria

For ischemic stroke group * Hemorrhagic Stroke * Previous Ischemic Stroke For control group * The expected life expense less than 3 years

Design outcomes

Primary

MeasureTime frameDescription
the odds ratio of omentin plasma concentration between cases and controlsup to 3 yearsThe circulation level of omentin will be assessed in cases and controls. Then the odds ratio will be statically analysed to detect whether omentin is asociated with ischemic stroke on protein level.
the frequency difference of single nucleotide polymorphism(SNP) of omentin in the enrolled subjectsup to 3 yearsThe SNP will be analysed in the recruited subjects. And the the frequency difference will be calculated to explore if any SNP is related to ischemic stroke.

Secondary

MeasureTime frameDescription
the Barthel index assessed for functional independence in activitiesup to 3 yearsThe Barthel index at the point of baseline, out-patient, 3rd month, 6th month, 1st year, 2nd year and the 3rd year after enrollment will be assessed for the functional independence in activities.
the NIHSS assessed for functional outcome of strokeup to 3 yearsNIHSS wil be used to assess neurological status at baseline or the point of stroke, the point of out-patient, 3 month, 6 month, 1 year, 2 year and the 3 year.
the number of re-stroke in case groupup to 3 yearsRecurrent of stroke will be monitored through out in case group.
the number of all cause deathup to 3 yearsThe number of all cause of death will be recorded in both groups.
the modified Rankin Scale assessed for functional disabilityup to 3 yearsTh functional disability will be assessed using the modified Rankin Scale at the time of baseline, out-patient, 3rd month, 6th month, 1st year, 2nd year and the 3rd year after enrollment.

Countries

China

Contacts

Primary ContactTian Ye, PhD
chhty@sina.com+86 13519131549

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026